Search Results 811-820 of 10437 for total t4

  1. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    Total Bilirubin ≤ 1.5 x ULN. In patients with a total bilirubin > 1.5 x ULN, if direct bilirubin < 1.0 X ULN, then patient is eligible. Aspartate ...

  2. Oncology (Medical) - Clinical trials

    The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better (overall response rate, ...

  3. Gastroenterology and Hepatology - Clinical trials

    The primary study hypothesis is that pembrolizumab will prolong progression-free survival (PFS) or overall survival (OS) compared to current SOC chemotherapy.

  4. Clinical trials - Oncology (Medical)

    ... total liver volume) to determine if there is an optimal lobar dose and embolic load. The Patient Group 2 primary objectives are to assess the association of ...

  5. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Serum total bilirubin ≤ 1.5 x ULN; or; Direct bilirubin ≤ ULN for patients with total bilirubin >1.5 x ULN. Exception for elevated bilirubin secondary to ...

  6. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

    ... complete response [CR] plus partial response [PR]), overall survival (OS), duration of response (DOR), time to progression (TTP). Participation eligibility.

  7. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

    total bilirubin levels >1.5 × ULN (excluding ... Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid ... TNFa and IL-2 armed adenoviruses ...

  8. Clinical trials - Oncology (Medical)

    The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer.

  9. Clinical trials - Oncology (Medical)

    The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer.

  10. Ablation therapy - Doctors & Departments - Mayo Clinic

    ... total knee replacement, Failed total hip replacement, Failed back syndrome, Radiculopathy, Neuropathic pain syndrome. Show more areas of focus for Ryan S. D ...